4 recruiting. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
| Phase 1 | 2 | Recruiting 2 |
Follow Blindness: new trials by email Literature Review of Blindness trials Research Report on Blindness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration Ixo-vec - Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | Phase 2 | Recruiting | Adverum Biotechnologies, Inc. | 15 | 2026-06-02 | 2026-08-05 |
| A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) OpCT-001 - Primary Photoreceptor Disease, Retinitis Pigmentosa (RP) | Phase 1 / Phase 2 | Recruiting | BlueRock Therapeutics | 54 | 2025-03-10 | 2026-10-15 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa AAVB-081 - Usher Syndrome, Type 1B | Phase 1 / Phase 2 | Recruiting | AAVantgarde Bio Srl | 15 | 2024-07-02 | 2025-05-02 |
| Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema DME lactose pill, DME levosulpiride, DR lactose pill - Diabetic Macular Edema, Diabetic Retinopathy | Phase 2 | Recruiting | Carmen Clapp | 120 | 2017-05-24 | 2025-11-18 |
Retinitis Pigmentosa (2) · Usher Syndromes (2) · Cone-Rod Dystrophies (1) · Diabetic Retinopathy (1) · Eye Diseases (1) · Macular Degeneration (1) · Macular Edema (1) · Retinal Degeneration (1) · Usher syndrome, type 1B (1)
Nervous System Diseases (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Retinal Diseases (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Vision Disorders (4) · Eye Diseases (3) · Retinal Degeneration (3) · Abnormalities, Multiple (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Deaf-Blind Disorders (2) · Deafness (2)
Sugars (1) · dimethylethylsilylimidazole (1)
AAVantgarde Bio Srl (1) · Adverum Biotechnologies, Inc. (1) · BlueRock Therapeutics (1) · Carmen Clapp (1)
United States (2) · Italy (1) · Mexico (1) · United Kingdom (1)
Adam Turpcu, PhD (1) · Carmen Clapp, Ph.D. (1) · Jakob Triebel, M.D. (1) · Ludivina Robles Osorio, M.D., Ph.D. (1) · Marlon R Garcia Roa, M.D. (1) · Renata Garcia Franco, M.D. (1)